Sponsor: University of Oxford
Target recruitment: Approx. 40 patients
Recruitment Period: 18 months from November 2014
Patients are allocated to one of three treatment arms
All patients either have surgery or a biopsy before and after six weeks exposure to either mifamurtide alone, Ifosfamide alone, or mifamurtide combined with Ifosfamide. Further treatment to a maximum of 36 or 42 weeks in total, with all patients being able to receive 36 weeks of mifamurtide treatment.